RxDoctor Payments Data

Santiago Garcia, MD

Interventional Cardiology · Cincinnati, OHNPI 1669517785

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $229,591 of the $359,568 with a category attached, or 63.9%. 19 manufacturers reported payments, led by Edwards Lifesciences at 59.3% of the total. 2025 is the largest year on record at $106,354, 5.6 times the $19,144 reported in 2019. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$359,568in general payments, 2019–2025

Across 706 payments — averaging $509.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$213K
  • Medtronic$60K
  • Boston Scientific$39K
  • Abbott$35K
  • Ancora Heart, Inc.$3K
  • B. Braun Interventional Systems Inc.$2K
  • plus $6K from 13 others
$3,242,919in research payments, 2019–2025

Across 822 payments — averaging $3945.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Edwards Lifesciences$1.8M
  • Boston Scientific$1M
  • Abbott$273K
  • Cathworks, Inc.$70K
  • Biotronik Inc.$69K
  • Medtronic$40K
  • plus $13K from 1 others

What the payments were for

  • Consulting fees$229,59164%
  • Speaking & faculty fees$38,08211%
  • Travel & lodging$69,58019%
  • Food & beverage$22,0226%
  • Education$120%
  • Other$2820%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$359,568 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio

Medicare billing

Part B allowed, 2024
$144,741
Medicare patients
297
Services billed
582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$15,785
Warfarin Sodium41$335
Metoprolol Succinate24$211
ClopidogrelClopidogrel Bisulfate14$198
Furosemide34$138
Lisinopril11$106
Metoprolol Tartrate20$33
Prednisone13$21

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →